close read more


Colorectal cancer
awareness month

Read more

Servier - Independent international pharmaceutical laboratory

logo twitter

employees, including  4,900 in France.

100 million

patients treated each day worldwide with Servier Group medicines.

23 %

of revenue from brand-name medicines invested in R&D in 2019/2020.

4.7 billion

euros in revenue in 2019/2020 comprising €3.3 billion for brand-name medicines and €1.4 billion for generic medicines.

3 therapeutic areas

oncology, immune-inflammatory and neurodegenerative diseases, cardiometabolism.

icon play
icon play

Join our teams!

We do everything possible for all Group employees to have the means to succeed, to adapt, to take on responsibilities and to grow. At Servier, you will be offered a unique and meaningful professional experience.

Colorectal cancer: screening too late

Colorectal cancer is a common disease. It is one of the most frequently diagnosed cancers in the world: it ranks third, behind lung cancer and liver cancer, and it affects almost as many women as men.

SMART – Servier Medical Art

SMART is Servier’s medical image bank dedicated to healthcare professionals. The diversity of the 3,000 free medical images available makes it easy to illustrate all types of presentations or publications.

The basis for our actions

Because passing on to future generations a world that can ensure access to quality health care for all is our vision for the future, at Servier, all over the world, we are ready to meet the health care challenges of tomorrow, for and with patients. Discover our corporate video.

icon play